Long-term Protection After Hepatitis B Vaccine
نویسندگان
چکیده
منابع مشابه
Long-term protection of hepatitis B vaccine in HIV-infected patients
Materials and methods Our database NADIS allows us to collect information from March 1986 to October 2013 (gender, age, CD4 count, HIVRNA and Hepatitis B surface antibody titers = HBs Ab > 10 IU / L.) Patients were included gradually after 3 Engerix B 20 hepatitis B vaccines at day 1, one month and 6 months later, conferring a rate of HBs ab > 10 IU /L. Then we observed the duration of protecti...
متن کاملLong-term hepatitis B vaccine in infants born to hepatitis B e antigen positive mothers.
Neonates of hepatitis B surface antigen (HBsAg) positive and hepatitis B encoded antigen (HBeAg) positive mothers received 10 micrograms of recombinant hepatitis B vaccine at months 0, 1, 6, or 0, 1, 2, 12, with or without immunoglobulin at birth, and were followed up to the age of 8 years for HBsAg, anti-HBc, and anti-HBs. Some were boosted at month 60. The overall vaccine protection at month ...
متن کاملDeterminants of Long-term protection after hepatitis B vaccination in infancy: a meta-analysis.
BACKGROUND The duration of protection after hepatitis B vaccination in early infancy is unclear and may be related to vaccination schedule, dosage, vaccine type and population characteristics. Factors potentially influencing waning immunity were assessed. METHODS A systematic review was performed. The main outcomes were prevalence of anti-hepatits B antibodies ≥ 10 mIU/mL after primary or boo...
متن کاملInfluenza vaccine and long-term protection.
Controlled trials of influenza vaccine' were conducted among employees of The British Petroleum Company in the winters of I963/64 and I964/65. The results did not support the efficacy of the vaccine and its use was abandoned (Cook, I965). The protective effects of the vaccine, if any, would be expected to be of short duration and of the order of one year. It was decided to conduct a retrospecti...
متن کاملThe factors influencing the immune response to hepatitis B vaccine and persistence of the protection.
Hepatitis B virus (HBV) infection and its sequelae which include cirrhosis and hepatocellular carcinoma is a major public health problem throught the world.The WHO strategy for effective control of HBV infection is vaccination with the surface antigen of virus(HBsAg).The results obtained from a large number of studies demonstrated that the vaccine induces a protective antibody resonse (anti-HB...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Infectious Diseases
سال: 2016
ISSN: 0022-1899,1537-6613
DOI: 10.1093/infdis/jiv750